Sentinel lymph node biopsy in patients with early-stage breast cancer: status of the National Clinical Trials
- 31 August 2003
- journal article
- review article
- Published by Elsevier in Surgical Clinics of North America
- Vol. 83 (4) , 901-910
- https://doi.org/10.1016/s0039-6109(03)00050-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Innovation in surgery: the rules of evidencePublished by Elsevier ,2002
- Multicenter Trial of Sentinel Node Biopsy for Breast Cancer Using Both Technetium Sulfur Colloid and Isosulfan Blue DyeAnnals of Surgery, 2001
- Sentinel Lymph Node Biopsy for Breast Cancer: A Suitable Alternative to Routine Axillary Dissection in Multi-Institutional Practice When Optimal Technique Is UsedJournal of Clinical Oncology, 2000
- Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients with Breast CancerAnnual Review of Medicine, 2000
- The Sentinel Node in Breast Cancer — A Multicenter Validation StudyNew England Journal of Medicine, 1998
- Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodesThe Lancet, 1997
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast CancerAnnals of Surgery, 1994
- NIH consensus conference. Treatment of early-stage breast cancerPublished by American Medical Association (AMA) ,1991
- Eight-Year Results of a Randomized Clinical Trial Comparing Total Mastectomy and Lumpectomy with or without Irradiation in the Treatment of Breast CancerNew England Journal of Medicine, 1989
- Ten-Year Results of a Randomized Clinical Trial Comparing Radical Mastectomy and Total Mastectomy with or without RadiationNew England Journal of Medicine, 1985